In addition, elevated SHP-1 expression has been associated with several types of tumors, such as epithelial ovarian cancers (63) and high-grade breast cancers (64), suggesting SHP-1 as a potential therapeutic target. This evidence concerns the gene NR0B2 and breast cancer.